We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > TGA

News List

Health Canada approves new drug to treat metastatic breast cancer through international and domestic joint reviews firstwordpharma
April 10, 2019
OTTAWA, April 9, 2019 /CNW/ - Canadians want improved access to the most recent and innovative treatment options for themselves and their families.
J&J withdraws controversial vaginal mesh from Australian market pharmafile
January 24, 2018
Johnson & Johnson has withdrawn its controversial vaginal mesh product from the Australian market after missing a deadline requiring all such products to carry warnings of potential side-effects
Amicus’ Galafold receives TGA approval for Fabry disease treatment in Australia pharmaceutical-technology
August 17, 2017
Amicus Therapeutics has received the Australian Therapeutic Goods Administration (TGA) approval for Galafold (Migalastat) to treat patients with Fabry disease (alpha-galactosidase A deficiency) in the country.

Previous page 1 2 Next page